EBITDA Growth
84.18%
Quarterly · Period ending:
CME EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported84.18%period ending
Latest reported84.18%period ending
CME Quarterly EBITDA YoY % (62.42% → 84.18%)
Year-over-year change
High-resolution chart · PNG
CME ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 84.1823% | |
| -35.0689% | |
| 19.6348% | |
| 34.8325% | |
| 0.1998% | |
| 13.9897% | |
| 10.528% | |
| 7.8357% | |
| 18.0367% | |
| 11.5979% | |
| -3.6484% | |
| 18.1875% | |
| 9.0855% | |
| 14.9694% | |
| 22.347% | |
| 2.3619% | |
| -18.1133% | |
| 15.3188% | |
| 17.7915% | |
| 34.2083% | |
| 77.2336% | |
| 5.8543% | |
| -21.9461% | |
| -10.8668% | |
| -21.5284% | |
| -6.1063% | |
| 42.5115% | |
| -3.6581% | |
| 34.2818% | |
| 3.4007% | |
| -7.8911% | |
| 23.8785% | |
| -3.8422% | |
| 16.9517% | |
| 10.1746% | |
| -4.1252% | |
| 8.1877% | |
| 10.3761% | |
| 18.613% | |
| 23.4604% | |
| 5.4983% | |
| 21.7757% | |
| 8.8384% | |
| -0.9304% | |
| 16.7119% | |
| 4.9225% | |
| 13.4779% | |
| 37.8298% | |
| 4.3918% | |
| -15.8303% | |
| 11.1936% | |
| -11.3274% | |
| 1.5204% | |
| 0.2151% | |
| -8.5062% | |
| -1.6559% | |
| -23.9888% | |
| 0.2987% | |
| -12.4938% | |
| -11.7144% | |
| 23.8252% | |
| 3.3613% | |
| 22.8259% | |
| 16.2437% | |
| 14.6817% | |
| 24.4876% | |
| 8.7282% | |
| -8.0883% | |
| -10.6563% | |
| 18.0479% | |
| 0.5164% | |
| 27.3825% | |
| 26.8566% | |
| 80.3975% | |
| 104.0648% | |
| 117.0815% | |
| 125.8809% | |
| 14.9295% | |
| 41.0671% | |
| 9.9533% | |
| 27.9167% | |
| 15.1761% | |
| 22.7518% | |
| 38.4816% | |
| 16.3475% | |
| 44.7993% | |
| 36.7334% | |
| 107.1002% | |
| 72.8554% | |
| 53.836% | |
| 56.8775% | |
| -9.8025% | |
| 28.9371% | |
| 38.1798% | |
| 40.5087% | |
| 73.4935% | |
| 16.1424% | |
| 62.4165% |